Chronic Myeloid Leukemia

Key Points

Key points are not available for this paper at this time.

Abstract

Chronic myeloid leukemia is a myeloproliferative neoplasm that can typically be effectively treated with TKIs, improving survival similar to that of a general age-matched population. Many patients require continuous TKI therapy. Therefore, TKI therapy should be selected with consideration of adverse effects, and patients should be helped to maximize adherence to TKI treatment.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Cite This Study

Jabbour et al. (Mon,) studied this question.

synapsesocial.com/papers/69d9a3fe2a25b240b7a3d3a4 https://doi.org/https://doi.org/10.1001/jama.2025.0220

Discussion

Journals

JAMA

Institutions

The University of Texas MD Anderson Cancer Center

References and Citations

Add This Paper to Your Research Feed

Any time a new paper drops it will be there.